Growth Stocks To Add to Your Watchlist - July 29th

Key Points

• Novo Nordisk A/S, Circle Internet Group, Welltower, Apollo Global Management, Incyte, Blackstone, and BlackRock are the seven growth stocks identified as having high trading volumes and potential for capital appreciation.
• Circle Internet Group's stock price reached $188.69, reflecting a notable increase during trading, though its P/E ratio indicates extreme valuation volatility.
• Welltower Inc., a real estate investment trust, experienced a significant gain of $7.55, signaling strong performance in the healthcare infrastructure sector with a market cap of $108.45 billion.

Novo Nordisk A/S, Circle Internet Group, Welltower, Apollo Global Management, Incyte, Blackstone, and BlackRock are the seven Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are shares of companies whose revenues and earnings are projected to grow substantially faster than the overall market or their industry peers. These companies typically reinvest most of their profits back into the business rather than paying dividends, leading investors to buy them primarily for capital appreciation. Consequently, growth stocks often trade at higher valuation multiples (like price-to-earnings ratios) than more mature, dividend-paying firms. These companies had the highest dollar trading volume of any Growth stocks within the last several days.

Novo Nordisk A/S (NVO)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.

Shares of NYSE:NVO traded down $14.70 during mid-day trading on Tuesday, hitting $54.30. The stock had a trading volume of 86,742,358 shares, compared to its average volume of 9,712,979. Novo Nordisk A/S has a 12-month low of $53.51 and a 12-month high of $139.74. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.56 and a current ratio of 0.74. The company has a market cap of $242.45 billion, a PE ratio of 16.06, a P/E/G ratio of 1.38 and a beta of 0.64. The company's 50 day moving average is $70.71 and its 200-day moving average is $73.51.

Read Our Latest Research Report on NVO

Circle Internet Group (CRCL)

Founded in 2013, Circle's mission is to raise global economic prosperity through the frictionless exchange of value. We intend to connect the world more deeply by building a new global economic system on the foundation of the internet, and to facilitate the creation of a world where everyone, everywhere can share value as easily as we can today share information, content, and communications.

Shares of CRCL traded up $3.33 during mid-day trading on Tuesday, reaching $188.69. The company's stock had a trading volume of 6,085,959 shares, compared to its average volume of 32,676,891. Circle Internet Group has a 1 year low of $64.00 and a 1 year high of $298.99. The firm has a market capitalization of $41.99 billion and a P/E ratio of -14,911.49.

Read Our Latest Research Report on CRCL

Welltower (WELL)

Welltower Inc. NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.

NYSE WELL traded up $7.55 during trading on Tuesday, reaching $165.84. 2,256,565 shares of the company's stock were exchanged, compared to its average volume of 2,974,368. The company has a current ratio of 4.23, a quick ratio of 4.23 and a debt-to-equity ratio of 0.46. Welltower has a fifty-two week low of $110.74 and a fifty-two week high of $165.87. The company's fifty day simple moving average is $153.77 and its 200-day simple moving average is $148.25. The firm has a market capitalization of $108.45 billion, a PE ratio of 95.34, a P/E/G ratio of 1.88 and a beta of 0.92.

Read Our Latest Research Report on WELL

Apollo Global Management (APO)

Apollo Global Management, Inc. is a private equity firm specializing in investments in credit, private equity, infrastructure, secondaries and real estate markets. The firm prefers to invest in private and public markets. The firm's private equity investments include traditional buyouts, recapitalization, distressed buyouts and debt investments in real estate, corporate partner buyouts, distressed asset, corporate carve-outs, middle market, growth, venture capital, turnaround, bridge, corporate restructuring, special situation, acquisition, and industry consolidation transactions.

APO stock traded down $1.70 during midday trading on Tuesday, reaching $147.00. The company had a trading volume of 1,272,509 shares, compared to its average volume of 3,615,904. The company has a market capitalization of $84.01 billion, a P/E ratio of 25.75, a PEG ratio of 1.70 and a beta of 1.59. Apollo Global Management has a 1 year low of $95.11 and a 1 year high of $189.49. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 0.34. The company has a 50 day moving average of $139.72 and a two-hundred day moving average of $142.55.

Read Our Latest Research Report on APO

Incyte (INCY)

Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas in the United States and internationally. The company offers JAKAFI (ruxolitinib) for treatment of intermediate or high-risk myelofibrosis, polycythemia vera, and steroid-refractory acute graft-versus-host disease; MONJUVI (tafasitamab-cxix)/MINJUVI (tafasitamab) for relapsed or refractory diffuse large B-cell lymphoma; PEMAZYRE (pemigatinib), a fibroblast growth factor receptor kinase inhibitor that act as oncogenic drivers in liquid and solid tumor types; ICLUSIG (ponatinib) to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia; and ZYNYZ (retifanlimab-dlwr) to treat adults with metastatic or recurrent locally advanced Merkel cell carcinoma, as well as OPZELURA cream for treatment of atopic dermatitis.

NASDAQ:INCY traded up $6.74 during mid-day trading on Tuesday, reaching $76.90. The stock had a trading volume of 2,373,936 shares, compared to its average volume of 1,866,771. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.04 and a quick ratio of 2.00. The stock has a market cap of $14.89 billion, a P/E ratio of 241.01, a PEG ratio of 0.59 and a beta of 0.68. Incyte has a fifty-two week low of $53.56 and a fifty-two week high of $83.95. The business's 50 day moving average is $68.02 and its 200 day moving average is $66.52.

Read Our Latest Research Report on INCY

Blackstone (BX)

Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.

Blackstone stock traded down $0.14 on Tuesday, reaching $176.80. 985,668 shares of the stock were exchanged, compared to its average volume of 4,292,270. The stock has a market cap of $129.00 billion, a PE ratio of 47.57, a PEG ratio of 1.55 and a beta of 1.65. Blackstone has a twelve month low of $115.66 and a twelve month high of $200.96. The firm has a fifty day moving average price of $149.73 and a two-hundred day moving average price of $150.43. The company has a current ratio of 0.74, a quick ratio of 0.75 and a debt-to-equity ratio of 0.61.

Read Our Latest Research Report on BX

BlackRock (BLK)

BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.

BLK traded up $0.48 during trading on Tuesday, reaching $1,118.30. 147,575 shares of the company's stock were exchanged, compared to its average volume of 788,192. The company has a market capitalization of $173.26 billion, a P/E ratio of 27.09, a PEG ratio of 2.27 and a beta of 1.41. The company has a quick ratio of 4.34, a current ratio of 4.34 and a debt-to-equity ratio of 0.38. The business has a 50 day moving average price of $1,030.13 and a 200 day moving average price of $977.80. BlackRock has a fifty-two week low of $773.74 and a fifty-two week high of $1,130.66.

Read Our Latest Research Report on BLK

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.